Published • loading... • Updated
NetraMark Signs New Contract To Analyze Phase 2 Neurodegeneration Trial Data With Contract Research Organization Partner
Summary by The Toronto Star
2 Articles
2 Articles
The Toronto StarReposted by 
Cambridge Times
Cambridge TimesNetraMark Signs New Contract To Analyze Phase 2 Neurodegeneration Trial Data With Contract Research Organization Partner
New agreement is a significant commercial milestone and the Company’s first with its contract research organization partnerAgreement expands NetraMark’s portfolio of AI-driven projects in central nervous system (CNS) disorders
·Toronto, Canada
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left2Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
